Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate

Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate

James R O’Dell,1 Stanley B Cohen,2 J Carter Thorne,3 Joel Kremer4 1Department of Rheumatology, Division of Rheumatology and Immunology, University of Nebraska Medical Center and the Omaha VA, Omaha, NE, USA; 2Department of Internal Medicine, Metroplex Clinical Research Center, University o...

Full description

Bibliographic Details
Main Authors: O’Dell JR, Cohen SB, Thorne JC, Kremer J
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:Open Access Rheumatology : Research and Reviews
Subjects:
biologic
claims
methotrexate
tumor necrosis factor
Online Access:https://www.dovepress.com/treatment-of-rheumatoid-arthritis-in-the-usa-premature-use-of-tumor-ne-peer-reviewed-article-OARRR

Internet

https://www.dovepress.com/treatment-of-rheumatoid-arthritis-in-the-usa-premature-use-of-tumor-ne-peer-reviewed-article-OARRR

Similar Items